Coming soon...

Something worth reading about HTA is coming.

Health technology assessment shapes which treatments reach patients and which don't. The reasoning behind those decisions is often more contested, and more interesting, than headlines suggest. Reasonably Accountable will be launching in August to dig into exactly that.

I'll be providing timely in-depth commentary on developments in HTA: NICE's latest guidance and appraisals, the methods debates that shape how value gets judged, and the decisions that set precedents others will follow. It's not just about what was decided, but whether the reasoning holds up.

Expect writing from a critical friend. Articles will be rigorous about methods and assumptions, clear about what the evidence does and doesn't support, and ready to call out weaknesses and faults. When good decisions are made, they'll be celebrated!

If you work in or around HTA, whether that's as a researcher, in industry, at a consultancy, or you're making the decisions being written about, the aim is to be genuinely useful to you. If you're simply curious about how health systems decide what to fund, you're just as welcome, and I'll take feedback on making the articles as accessible as possible: that's part and parcel of accountability.

The first posts will land in early August, and will only be accessible to members, but there's no paywall. Subscribe now and the first posts will arrive in your inbox the moment they're published — no need to remember to check back.